These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 24100689

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Castration resistant prostate cancer 2011].
    Miller K.
    Aktuelle Urol; 2011 Mar; 42(2):95-102. PubMed ID: 21437832
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Galeterone activity in castration-resistant prostate cancer.
    Yaqub F.
    Lancet Oncol; 2015 Jan; 16(1):e10. PubMed ID: 25638544
    [No Abstract] [Full Text] [Related]

  • 46. Targeting the androgen receptor signaling pathway in advanced prostate cancer.
    Chung C, Abboud K.
    Am J Health Syst Pharm; 2022 Jul 22; 79(15):1224-1235. PubMed ID: 35390118
    [Abstract] [Full Text] [Related]

  • 47. Abiraterone for treatment of metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.
    Zhou ZR, Liu SX, Zhang TS, Xia J, Li B.
    Asian Pac J Cancer Prev; 2014 Jul 22; 15(3):1313-20. PubMed ID: 24606458
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Therapies for castration-resistant prostate cancer in a new era: The indication of vintage hormonal therapy, chemotherapy and the new medicines.
    Mizokami A, Kadono Y, Kitagawa Y, Izumi K, Konaka H.
    Int J Urol; 2017 Aug 22; 24(8):566-572. PubMed ID: 28577511
    [Abstract] [Full Text] [Related]

  • 53. Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade.
    Obinata D, Hashimoto S, Uchida H, Nakahara K, Yoshizawa T, Mochida J, Yamaguchi K, Takahashi S.
    BMC Urol; 2023 Apr 28; 23(1):74. PubMed ID: 37118708
    [Abstract] [Full Text] [Related]

  • 54. Enzalutamide after docetaxel and abiraterone therapy in metastatic castration-resistant prostate cancer.
    Schmid SC, Geith A, Böker A, Tauber R, Seitz AK, Kuczyk M, von Klot C, Gschwend JE, Merseburger AS, Retz M.
    Adv Ther; 2014 Feb 28; 31(2):234-41. PubMed ID: 24442834
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies.
    Bellmunt J, Kheoh T, Yu MK, Smith MR, Small EJ, Mulders PF, Fizazi K, Rathkopf DE, Saad F, Scher HI, Taplin ME, Davis ID, Schrijvers D, Protheroe A, Molina A, De Porre P, Griffin TW, de Bono JS, Ryan CJ, Oudard S.
    Eur Urol; 2016 May 28; 69(5):924-32. PubMed ID: 26508309
    [Abstract] [Full Text] [Related]

  • 59. Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
    Smith MR, Saad F, Rathkopf DE, Mulders PFA, de Bono JS, Small EJ, Shore ND, Fizazi K, Kheoh T, Li J, De Porre P, Todd MB, Yu MK, Ryan CJ.
    Eur Urol; 2017 Jul 28; 72(1):10-13. PubMed ID: 28314611
    [Abstract] [Full Text] [Related]

  • 60. The clinical benefit of sequential therapy with androgen receptor axis-targeted agents alone in patients with castration-resistant prostate cancer: A propensity score-matched comparison study.
    Naito Y, Kato M, Kawanishi H, Yuguchi Y, Yuba T, Ishikawa T, Hattori K, Yamamoto A, Sano T, Matsukawa Y, Kimura T, Nishikimi T, Hattori R, Tsuzuki T, Gotoh M.
    Prostate; 2020 Nov 28; 80(15):1373-1380. PubMed ID: 32914895
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.